The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targetsDawn Q. Chong, Andrew X. Zhu|Oncotarget|2016Cited by 105
NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling ProjectJessica L. Petrick, Katherine A. McGlynn, Andrew T. Chan et al.|Cancer Prevention Research|2015Cited by 94